Trump officials admit the No Surprises Act is being gamed, after huge payments
The administration says doctors are exploiting the law, forcing regulators to confront a fix they cannot ignore.

Trump administration officials acknowledged problems with the No Surprises Act that have led to huge payments. The consequence is a renewed regulatory fight that could reshape billing risk and compliance priorities for healthcare leaders.
For the first time, officials have acknowledged problems with the No Surprises Act, which has led to huge payments. That is the headline version of a much bigger problem: a law designed to stop patients from getting hit with surprise bills is now producing outcomes that officials themselves say are not working as intended.
The administration is not treating this as a minor glitch. By saying the law is being “gamed” by doctors, the officials are effectively widening the aperture from “bad luck in billing operations” to “system-level incentives that reward certain behaviors.” For executives and boards, that distinction matters because it changes how you think about risk. If the issue is operational, you tighten processes. If it is incentive driven, you prepare for regulatory rewrites, enforcement attention, and potentially new constraints on how bills are priced and routed.
To understand why this acknowledgement is a big deal, zoom out one layer to how surprise billing typically works in healthcare. Patients often believe they are getting a straightforward in-network experience, then discover that a single part of the encounter is treated differently by a billing system. The No Surprises Act was meant to curb those moments by setting guardrails around out-of-network billing outcomes and limiting what patients should have to absorb. But healthcare billing is not just math. It is an ecosystem of coding practices, payer contracting, provider workflows, and administrative interpretation.
When officials say the law is being gamed, the subtext is that parts of that ecosystem have adapted. That is a classic regulatory pattern. New rules enter the market. Actors that benefit from ambiguity test boundaries. Over time, the market learns how to route around the intent, even when the letter of the law is technically complied with. The “huge payments” mentioned in the report indicate the stakes are not theoretical. Large dollars create pressure from payers, employers, consumer advocates, and regulators all at once, because the law’s economic outcome is now part of the political and fiscal debate.
From a governance perspective, the biggest second-order issue is the difference between “compliance” and “outcomes.” A provider or billing organization can be compliant on paper while still generating the kind of payment patterns that regulators are now publicly flagging. That is where boards should pay attention. When a law starts drawing headlines for the wrong reason, management teams can find themselves firefighting in two directions: defending billing practices in the language of compliance, while also redesigning operations to produce outcomes aligned with enforcement priorities.
This is also where the payer/provider relationship becomes a spotlight. Payers want predictable cost containment. Providers want fair reimbursement and workable administrative processes. The No Surprises Act sits right in the middle. If officials are signaling that the current structure is producing “huge payments,” that could mean payers escalate contracting pressure, providers renegotiate processes, and administrators tighten documentation and coding rules. Even without new legislation immediately, the market often behaves as if new enforcement is coming, because nobody wants to be the next example.
For healthcare leaders, the practical question becomes: how much of your billing posture is built for today’s interpretation versus tomorrow’s enforcement mood. The report’s key fact is the first acknowledgement by officials that there are real problems under the No Surprises Act. That suggests the government is moving from diagnosis to response. When regulators publicly connect a law to problematic payment outcomes, the next steps usually include clarifications, guidance, audits, or rulemaking processes that alter how actors across the industry think about risk.
Peers should treat this as a signal to revisit the whole billing chain, not just the parts that touch patients. Boards that are used to approving compliance dashboards should ask for outcome-based reporting: how billing patterns look relative to the law’s intended protections and where “edge cases” might be concentrating. The headline is about doctors being accused of gaming. But the board-level takeaway is broader: if officials are now acknowledging problems that have led to huge payments, the compliance environment for the entire ecosystem is about to tighten, and the organizations that adapt fastest will be the ones less likely to get caught flat-footed.
This story's Key Insights and Take-aways are locked.
Create a free account to unlock Executive Actions for one credit.
Register to UnlockAlways free for Executives Club members. Join the Club
More in Politics

House passes $1.15 trillion defense bill, Republicans push through while Democrats call it embracing war
The vote clears a massive price tag for defense policy, but the political fight over Iran shifts board-level risk appetites.

Senate panel advances $35 private-insulin cap by 17-5 vote, but fate stays unclear
A bipartisan committee sends the $35 cap forward, yet uncertainty ahead means providers, insurers, and drug makers should brace.

WHO warns Ebola is outpacing response, forcing a faster global containment scramble
The outbreak’s speed is beating preparedness, and decision-makers need to understand what that breaks in the system.

